T1	CHEM 74 85	vatiquinona
T3	PROC 137 143	tratar
T4	DISO 147 167	ataxia de Friedreich
#2	AnnotatorNotes T4	C0016719; Friedreich Ataxia; Disease or Syndrome
T5	DISO 173 194	condición neurológica
T6	PROC 215 230	Estudio abierto
T7	Date 231 244	a largo plazo
T8	PROC 250 284	evaluar la seguridad y la eficacia
T9	CHEM 288 299	vatiquinona
T10	LIVB 303 312	pacientes
#3	AnnotatorNotes T10	C0030705; Patients; Patient or Disabled Group
T11	DISO 317 337	ataxia de Friedreich
#4	AnnotatorNotes T11	C0016719; Friedreich Ataxia; Disease or Syndrome
T12	DISO 362 382	ataxia de Friedreich
#5	AnnotatorNotes T12	C0016719; Friedreich Ataxia; Disease or Syndrome
T13	DISO 390 438	enfermedad neurodegenerativa autosómica recesiva
T14	ANAT 468 484	sistema nervioso
#6	AnnotatorNotes T14	C0027763; Nervous system structure; Body System | C1269560; Entire nervous system; Body System
T15	ANAT 490 497	corazón
#7	AnnotatorNotes T15	C0018787; Heart; Body Part, Organ, or Organ Component | C1281570; Entire heart; Body Part, Organ, or Organ Component
T16	DISO 523 543	Ataxia de Friedreich
#8	AnnotatorNotes T16	C0016719; Friedreich Ataxia; Disease or Syndrome
T17	LIVB 576 583	persona
#9	AnnotatorNotes T17	C0027361; Persons; Population Group
T18	PROC 594 608	consentimiento
T19	LIVB 630 638	Personas
#10	AnnotatorNotes T19	C0027361; Persons; Population Group
T20	DISO 643 645	AF
#11	AnnotatorNotes T20	C0015625; Fanconi Anemia; Disease or Syndrome | C0016719; Friedreich Ataxia; Disease or Syndrome
T21	PROC 668 683	estudio clínico
#12	AnnotatorNotes T21	C0008972; Clinical Research; Research Activity | C0008976; Clinical Trials; Research Activity
T22	Date 788 794	actual
T25	PROC 866 887	método anticonceptivo
#14	AnnotatorNotes T25	C0700589; Contraceptive methods; Therapeutic or Preventive Procedure
T26	DEVI 905 914	implantes
#15	AnnotatorNotes T26	C0021102; Implants; Medical Device
T27	Route 916 927	inyectables
T28	DEVI 929 948	parche transdérmico
#16	AnnotatorNotes T28	C0991556; Transdermal System; Medical Device
T29	Form 929 935	parche
T30	Route 936 948	transdérmico
T32	Route 966 972	orales
T33	PROC 985 1003	métodos de barrera
#18	AnnotatorNotes T33	C0004764; Contraception, Barrier; Therapeutic or Preventive Procedure
T34	DEVI 1006 1032	dispositivos intrauterinos
#19	AnnotatorNotes T34	C0021900; Intrauterine Devices; Medical Device
T35	PROC 1077 1091	consentimiento
T36	Duration 1098 1105	30 días
T38	CHEM 1137 1159	medicamento en estudio
T39	PROC 1168 1174	visita
T40	LIVB 1207 1214	hombres
#20	AnnotatorNotes T40	C0025266; Male population group; Population Group | C0086418; Homo sapiens; Human
T41	Neg_cue 1237 1239	no
T42	PROC 1240 1251	donar semen
T43	Negated 1240 1251	donar semen
T44	Duration 1281 1297	al menos 30 días
T46	CHEM 1329 1340	medicamento
#21	AnnotatorNotes T46	C0013227; Pharmaceutical Preparations; Pharmacologic Substance | C0304228; Proprietary drug, NOS; Pharmacologic Substance | C0456386; Medicament; Pharmacologic Substance
T47	PROC 1349 1355	visita
T48	Neg_cue 1407 1413	ningún
T50	PROC 1419 1440	método anticonceptivo
#22	AnnotatorNotes T50	C0700589; Contraceptive methods; Therapeutic or Preventive Procedure
T51	Negated 1419 1440	método anticonceptivo
T52	PROC 1472 1495	método de doble barrera
T55	Date 1580 1586	actual
T56	PROC 1605 1627	estudio intervencional
T57	PHYS 1632 1640	Embarazo
#25	AnnotatorNotes T57	C0032961; Pregnancy; Organism Function
T58	PHYS 1643 1652	lactancia
#26	AnnotatorNotes T58	C0006147; Breast Feeding; Organism Function | C0022925; Lactation; Organ or Tissue Function
T59	Date 12 16	2022
T60	PROC 44 131	Estudio para determinar si la vatiquinona, medicación del estudio, es segura y efectiva
T61	PROC 780 787	estudio
T23	LIVB 804 830	mujeres y hombres fértiles
T24	Route 905 914	implantes
T31	CHEM 950 983	anticonceptivos orales combinados
T37	PROC 1263 1270	estudio
T45	DEVI 1505 1533	preservativo con espermicida
T2	CHEM 87 109	medicación del estudio
